[The impact of the dosage of intraoperative opioids on postoperative survival outcomes in patients with pancreatic cancer].

Zhang, W H; Liu, X J; Zhao, L Y; Lin, S Y; Teng, L; Dai, J Z; Shao, H X; Zou, H C

Zhang, W H; Liu, X J; Zhao, L Y; Lin, S Y; Teng, L; Dai, J Z; Shao, H X; Zou, H C.

Afiliação

Zhang WH; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Liu XJ; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Zhao LY; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Lin SY; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Teng L; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Dai JZ; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Shao HX; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Zou HC; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.

Zhonghua Yi Xue Za Zhi ; 102(39): 3121-3126, 2022 Oct 25.

Article em Zh | MEDLINE | ID: mdl-36274596

Assuntos

Analgésicos Opioides; Neoplasias Pancreáticas; Humanos; Estudos Retrospectivos; Neoplasias Pancreáticas/cirurgia; Fentanila; Neoplasias Pancreáticas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Analgésicos Opioides Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google